相关实验视频
Updated: Jul 5, 2025

07:38
Strategies for Assessing Autistic-Like Behaviors in Mice
Published on: September 20, 2024
997
用大麻素治疗自闭症谱系障碍的症状
Adi Aran1,2, Dalit Cayam Rand1,2
1Neuropediatric Unit, Shaare Zedek Medical Center, Jerusalem, Israel.
Expert opinion on emerging drugs
|January 16, 2024
概括
大麻 (CBD) 显示出治疗自闭症谱系障碍 (ASD) 核心症状和行为问题的潜力. 虽然早期研究是有希望的,但需要进一步的安慰剂对照试验来确认疗效和安全性.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 儿科 儿科 儿科
背景情况:
- 自闭症谱系障碍 (ASD) 影响约3%的学龄儿童,其特点是社会沟通缺陷和重复行为.
- 目前缺乏对ASD核心症状的治疗方法; 现有的治疗易怒症的药物有效性和副作用有限.
- 大麻素,特别是大麻 (CBD),正在作为一种潜在的治疗选择进行研究.
研究的目的:
- 审查现有的文献和正在进行的临床试验,用于治疗ASD的大麻素治疗.
- 评估CBD和CBD丰富的大麻提取物在ASD患者中的疗效和安全性.
主要方法:
- 对不受控制的病例系列和安慰剂受控研究的审查.
- 从涉及CBD丰富的大麻提取物和纯CBD的临床试验数据的分析.
- 对针对脆弱X综合征中社会回避的研究进行审查.
主要成果:
- 不受控制的研究表明,使用富含CBD的大麻提取物可以改善ASD核心症状和行为挑战.
- 对CBD和CBD丰富的提取物用于ASD的安慰剂控制研究显示混合的疗效结果.
- 一项对纯CBD用于脆弱X综合征中社会回避的安慰剂对照研究也产生了混合的结果.
- 研究通常表明,CBD治疗的安全性和耐受性很好.
结论:
- 目前的数据表明,CBD和富含CBD的大麻提取物对ASD相关缺陷的潜在益处.
- 在广泛采用CBD治疗ASD之前,需要从正在进行的安慰剂对照试验中获得进一步的结果.
- CBD显示出良好的安全性,因此需要继续进行研究.
相关概念视频
Autism Spectrum Disorder
98
Autism spectrum disorder (ASD) is a neurodevelopmental condition marked by persistent deficits in social communication and interaction alongside restrictive and repetitive behaviors or interests. ASD is sometimes accompanied by intellectual impairment.
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
98
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
279
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
279
Operant Conditioning Intervention
58
Operant conditioning serves as a foundational principle in therapeutic interventions aimed at modifying maladaptive behaviors. Central to this approach is the notion that behaviors, both adaptive and maladaptive, are learned through reinforcement. By analyzing the environmental factors that reinforce problematic behaviors, clinicians can design interventions to weaken these reinforcements and replace maladaptive behaviors with healthier alternatives.
In operant conditioning, behaviors that are...
In operant conditioning, behaviors that are...
58
Alzheimer's Disease: Treatment
195
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
195
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
197
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
197
Parkinson's Disease: Treatment
272
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
272

